Short or Long Antibiotic Regimes in Orthopaedics (SOLARIO): a randomised controlled open-label non-inferiority trial of duration of systemic antibiotics in adults with orthopaedic infection treated operatively with local antibiotic therapy

Maria Dudareva, Michelle Kümin, Werner Vach, Klaus Kaier, Jamie Ferguson, Martin McNally, Matthew Scarborough, Maria Dudareva, Michelle Kümin, Werner Vach, Klaus Kaier, Jamie Ferguson, Martin McNally, Matthew Scarborough

Abstract

Background: Orthopaedic infections, such as osteomyelitis, diabetic foot infection and prosthetic joint infection, are most commonly treated by a combination of surgical debridement and a prolonged course of systemic antibiotics, usually for at least 4-6 weeks. Use of local antibiotics, implanted directly into the site of infection at the time of surgery, may improve antibiotic delivery and allow us to shorten the duration of systemic antibiotic therapy, thereby limiting the frequency of side effects, cost and selection pressure for antimicrobial resistance.

Methods: SOLARIO is a multicentre open-label randomised controlled non-inferiority trial comparing short and long systemic antibiotic therapy alongside local antibiotic therapy. Adult patients with orthopaedic infection, who have given informed consent, will be eligible to participate in the study provided that no micro-organisms identified from deep tissue samples are resistant to locally implanted antibiotics. Participants will be randomised in a 1:1 ratio to receive either a short course (≤ 7 days) or currently recommended long course (≥ 4 weeks) of systemic antibiotics. The primary outcome will be treatment failure by 12 months after surgery, as ascertained by an independent Endpoint Committee blinded to treatment allocation. An absolute non-inferiority margin of 10% will be used for both per-protocol and intention-to-treat populations. Secondary outcomes will include probable and definite treatment failure, serious adverse events, treatment side effects, quality of life scores and cost analysis.

Discussion: This study aims to assess a treatment strategy that may enable the reduction of systemic antibiotic use for patients with orthopaedic infection. If this strategy is non-inferior, this will be to the advantage of patients and contribute to antimicrobial stewardship.

Trial registration: Clinicaltrials.gov, NCT03806166. Registered on 11 November 2019.

Keywords: Antibiotic; Carrier; Diabetic foot; Duration; Local antibiotic therapy; Osteomyelitis; Prosthetic joint infection; Revision.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flow diagram of participant enrolment, randomisation, treatment and follow-up within the SOLARIO study
Fig. 2
Fig. 2
SPIRIT Schedule of enrolment, interventions and assessments in the SOLARIO study

References

    1. Office for National Statistics. Prescription cost analysis, England 2016. 30 March 2017. . Accessed 30 Nov 2017.
    1. Conterno LO, Turchi MD. Systemic antibiotics for treating chronic osteomyelitis in adults. Cochrane Database Syst Rev. 2013;9:CD004439.
    1. Li HK, Rombach I, Zambellas R, Walker AS, McNally MA, Atkins BL, et al. Oral versus intravenous antibiotics for bone and joint infection. N Engl J Med. 2019;380:425–436. doi: 10.1056/NEJMoa1710926.
    1. Public Health England. English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Report 2018.
    1. Wintenberger C, Guery B, Bonnet E, Castan B, Cohen R, Diamantis S, et al. Proposal for shorter antibiotic therapies. Med Mal Infect. 2017;47(2):92–141. doi: 10.1016/j.medmal.2017.01.007.
    1. Defez C, Fabbro-Peray P, Bouziges N, Gouby A, Mahamat A, Daures JP, Sotto A. Risk factors for multidrug-resistant Pseudomonas nosocomial infection. J Hosp Infect. 2004;57:209–216. doi: 10.1016/j.jhin.2004.03.022.
    1. Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, et al. Community-associated extended-spectrum beta-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis. 2013;56(5):641–648. doi: 10.1093/cid/cis942.
    1. Ben-Ami R, Olshtain-Pops K, Krieger M, Oren I, Bishara J, Dan M, et al. Antibiotic exposure a risk factor for fluconazole-resistant Candida bloodstream infection. Antimicrob Agents Chemother. 2012;56(5):2518. doi: 10.1128/AAC.05947-11.
    1. Lew DP, Waldvogel FA. Osteomyelitis. Lancet. 2004;364(9431):369–367. doi: 10.1016/S0140-6736(04)16727-5.
    1. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56(1):1–10. doi: 10.1093/cid/cis966.
    1. Parvizi J, Gehrke T. Proceedings of the International Consensus Meeting on Periprosthetic Joint Infection. 2013.
    1. Stengel D, Bauwens K, Sehouli J, Ekkernkamp A, Porzsolt F. Systematic review and meta-analysis of antibiotic therapy for bone and joint infections. Lancet Infect Dis. 2001;1(3):175–188. doi: 10.1016/S1473-3099(01)00094-9.
    1. Spellberg B, Lipsky BA. Systemic antibiotic therapy for chronic osteomyelitis in adults. Clin Infect Dis. 2012;54(3):393–407. doi: 10.1093/cid/cir842.
    1. Salvati ER, Callagan JJ, Brause BD, Klein RF, Small RD. Reimplantation in infection. Elution of gentamicin from cement and beads. Clin Orthop Relat Res. 1986;207:83.
    1. Klemm KW. Antibiotic bead chains. Clin Orthop Relat Res. 1993;295:63–76.
    1. Henry SL, Hood GA, Seligson D. Long-term implantation of gentamicin-polymethylmethacrylate antibiotic beads. Clin Orthop Relat Res. 1993;295:47–53.
    1. Della Valle AG, Bostrom M, Brause B, Harney C, Salvati EA. Effective bactericidal activity of tobramycin and vancomycin eluted from acrylic bone cement. Acta Orthop Scand. 2001;72(3):237–240. doi: 10.1080/00016470152846547.
    1. McNally MA, Ferguson JY, Lau ACK, Diefenbeck M, Scarborough M, Ramsden AJ, et al. Single-stage treatment of chronic osteomyelitis with a new absorbable, gentamicin-loaded, calcium sulphate/hydroxyapatite biocomposite. A prospective series of 100 cases. Bone Joint J. 2016;98-B:1289–1296. doi: 10.1302/0301-620X.98B9.38057.
    1. Ferguson JY, Dudareva M, Riley ND, Stubbs D, Atkins BL, McNally MA. The use of a biodegradeable antibiotic-loaded calcium sulphate carrier containing tobramycin for the treatment of chronic osteomyelitis: a series of 195 cases. Bone Joint J. 2014;96-B(6):829–836. doi: 10.1302/0301-620X.96B6.32756.
    1. Ferguson JY, Diefenbeck M, McNally MA. Ceramic biocomposites as biodegradable antibiotic carriers in the treatment of bone infections. J Bone Joint Infect. 2017;2:38. doi: 10.7150/jbji.17234.
    1. Barth RE, Vogely HC, Hoepelman AIM, Peters EJG. To bead or not to bead? Treatment of osteomyelitis and prosthetic joint-associated infections with gentamicin bead chains. Int J Antimicrob Agents. 2011;38:371–375. doi: 10.1016/j.ijantimicag.2011.03.008.
    1. Walenkamp GHIM, Vree TB, van Rens TJG. Gentamicin-PMMA beads. Pharmacokinetic and nephrotoxicological study. Clin Orthop Relat Res. 1986;205:171.
    1. Haydon RC, Blaha JD, Mancinelli C, Koike K. Audiometric thresholds in osteomyelitis patients treated with gentamicin-impregnated methylmethacrylate beads (Septopal) Clin Orthop Relat Res. 1993;295:43–46.
    1. Pfoerringer D, Obermeier A, Kiokekli M, Buechner H, Vogt S, Stemberger A, et al. Antimicrobial formulations of absorbable bone substitute materials as drug carriers based on calcium sulfate. Antimicrob Agents Chemother. 2016;60(7):3897. doi: 10.1128/AAC.00080-16.
    1. Wahl P, Guidi M, Benninger E, Roenn K, Gautier E, Buclin T, et al. The levels of vancomycin in the blood and the wound after the local treatment of bone and soft-tissue infection with antibiotic-loaded calcium sulphate as carrier material. Bone Joint J. 2017;99-B(11):1537–1544. doi: 10.1302/0301-620X.99B11.BJJ-2016-0298.R3.
    1. Stockley I, Mockford BJ, Hoad-Reddick A, Norman P. The use of two-stage exchange arthroplasty with depot antibiotics in the absense of long-term antibiotic therapy in infected total hip replacement. J Bone Joint Surg Br. 2008;90-B:145–148. doi: 10.1302/0301-620X.90B2.19855.
    1. Howlin RP, Brayford MJ, Webb JS, Cooper JJ, Aiken SS, Stoodley P. Antibiotic-loaded synthetic calcium sulfate beads for prevention of bacterial colonization and biofilm formation in periprosthetic infections. Antimicrob Agents Chemother. 2015;59:111. doi: 10.1128/AAC.03676-14.
    1. Stravinskas M, Horstmann P, Ferguson J, Hettwer W, Nilsson M, Tarasevicius S, et al. Pharmacokinetics of gentamicin eluted from a regenerating bone graft substitute. In vitro and clinical release studies. Bone Joint Res. 2016;5:427–435. doi: 10.1302/2046-3758.59.BJR-2016-0108.R1.
    1. Van Moojen DJ, Hentenaar B, Vogely CH, Verbout AJ, Castelein RM, Dhert WJ. In vitro release of antibiotics from commercial PMMA beads and articulating hip spacers. J Arthroplast. 2008;23(8):1152. doi: 10.1016/j.arth.2007.08.020.
    1. Buchholz HW, Elson RA, Engelbrecht E, Lodenkaemper H, Roettger J, Siegel A. Management of deep infection of total hip replacement. J Bone Joint Surg Br. 1981;63-B(3):342. doi: 10.1302/0301-620X.63B3.7021561.
    1. Calhoun JH, Henry SL, Anger DM, Cobos JA, Mader JT. The treatment of infected nonunions with gentamicin-polymethylmethacrylate antibiotic beads. Clin Orthop Relat Res. 1993;295:23–27.
    1. Klemm K. The use of antibiotic-containing bead chains in the treatment of chronic bone infections. Clin Microbiol Infect. 2001;7:23–31. doi: 10.1046/j.1469-0691.2001.00186.x.
    1. Taggart T, Kerry RM, Norman P, Stockley I. The use of vancomycin-impregnated cement beads in the management of infection of prosthetic joints. J Bone Joint Surg Br. 2002;84-B:70–72. doi: 10.1302/0301-620X.84B1.0840070.
    1. Hoad-Reddick DA, Evans CR, Norman P, Stockley I. Is there a role for extended antibiotic therapy in a two-stage revision of the infected knee arthroplasty? J Bone Joint Surg Br. 2004;87-B:171–174. doi: 10.1302/0301-620X.87B2.15640.
    1. Blaha JD, Calhoun JH, Nelson CL, Henry SL, Seligson D, Esterhai JL, et al. Comparison of the clinical efficacy and tolerance of gentamicin PMMA beads on surgical wire versus combined and systemic therapy for osteomyelitis. Clin Orthop Relat Res. 1993;295:8–12.
    1. Nelson CL, Evans RP, Blaha JD, Calhoun J, Henry SL, Patzakis MJ. A comparison of gentamicin-impregnated polymethylmethacrylate bead implantation to conventional parenteral antibiotic therapy in infected total hip and knee arthroplasty. Clin Orthop Related Res. 1993;295:96–101.
    1. Shih HN, Shih LY, Wong YC. Diagnosis and treatment of subacute osteomyelitis. J Trauma. 2005;58:83–87. doi: 10.1097/01.TA.0000114065.25023.85.
    1. Metsemakers WJ, Morgenstern M, McNally MA, Moriarty TF, McFadyen I, Scarborough M, et al. Fracture-related infection: a consensus on definition from an international expert group. Injury. 2018;49:505–510. doi: 10.1016/j.injury.2017.08.040.
    1. King MT, Viney R, Smith DP, Hossain I, Street D, Savage E, et al. Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer. Br J Cancer. 2012;106:638–645. doi: 10.1038/bjc.2011.552.
    1. Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B, et al. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet. 2015;385(9971):875–882. doi: 10.1016/S0140-6736(14)61233-2.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj